Compliance, Cultivation, Legislation and Medical Evaluation

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Compliance

Cultivation

Legislation

Medical Evaluation

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Cannabis Law Report

JANUARY 30, 2019

Along with Senator Feinstein, I introduced legislation that expands research into a derivative of marijuana known as cannabidiol, or CBD. Senator Feinstein and I wrote to DOJ and Health and Human Services (HHS) on two occasions requesting that a scientific and medical evaluation of CBD be conducted. Access the full document at.

Research and Development

Research and Development DEA CBD Law

Further Consideration of the STATES Act

Cannabis Law Report

MARCH 25, 2019

Numerous attempts to introduce legislation to relax the provisions that placed cannabis on Schedule I of the Controlled Substances Act [“CSA”] have been made beginning in 1981 [i]. Both paths are complex processes in which scientific, medical, policy and political forces have influence. This Bill also died in committee [ii].

Banking

Banking Law Marijuana State Laws

Medical Cannabis Brief

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Further Consideration of the STATES Act

Stay Connected